Tender detail
Open house pharmaceutical discount agreements for the active substance Ponesimod, ATC L04AE04
Summary
The tender concerns non-exclusive discount agreements for medicines containing the active substance Ponesimod (ATC L04AE04) under an Open House model. The contracting period is 01 November 2026 to 31 October 2028, with contracts able to be concluded at any time. Medicines listed on the BfArM list as pediatric medicines are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.